NDC 55714-2572 – Post - Vaccination

Influenza A Virus 30 [hp_X]/mL; Influenza B Virus 30 [hp_X]/mL; Measles Virus 30 [hp_X]/mL; Human Sputum, Bordetella Pertussis Infected 30 [hp_X]/mL; Aconitum… · Liquid · Oral

Human Otc Drug

Product NDC55714-2572

Product details

Brand name
Post - Vaccination
Generic name
Influenzinum, Morbillinum, Pertussinum, Aconitum nap., Alumina, Antimon. tart., Arsenicum alb., Baptisia, Belladonna, Bryonia, Cinchona, Crotalus horridus, Gelsemium, Kali bic., Lachesis, Ledum, Merc. viv., Mezereum, Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Silicea, Sulphur, Thuja occ., Vaccinium, Apis mel., Echinacea, Hypericum
Labeler
Newton Laboratories, Inc.
Dosage form
Liquid
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
May 3, 2021
Listing expires
December 31, 2026
Pharmacologic class
Non-Standardized Plant Allergenic Extract; Standardized Insect Venom Allergenic Extract

Active ingredients

Uses, dosage, side effects and warnings for Post-Vaccination →

Package NDC codes (1)

Package NDCDescriptionSince
55714-2572-130 mL in 1 BOTTLE, GLASS (55714-2572-1)May 3, 2021

Other Post-Vaccination products